Dr Helen Blade – Helen.Blade@astrazeneca.com (Chair)

I graduated from Liverpool University with a PhD under Prof. Matt Rosseinsky in the field of functional materials, linking the crystal structure of a material to its properties.

As an associate principal scientist (structural science) working in AstraZeneca, Macclesfield since 2008, I have continued to work in this field and have recently been leading the establishment of crystal structure assessment to predict and explain the properties of pharmaceutical materials.

Dr Cheryl Doherty – cheryl.x.doherty@gsk.com (Vice chair) 

I am currently working in the Materials Sciences team at GSK. I work in a multi-disciplinary team developing dosage forms for drug candidates. This includes using molecular modelling, crystallography and statistical analyses of structural information to design a program of action to shape the experimental screening, characterisation and analysis of the API as well as guiding the dosage form development. This can be on candidates from early research (before first in human studies) through to Phase III clinical trial candidates. I am a member of the British Crystallographic Association, a Fellow of the Royal Society of Chemistry and a member of the Diamond (Synchrotron) Industrial Science Committee.

Dr David Beveridge – david.beveridge@harmantechnology.com (Secretary)

I work for HARMAN technology Ltd (successor to Ilford Ltd), one of the few companies still making traditional silver halide based photographic materials. I am basically an inorganic/analytical chemist, and I use X-Ray Fluorescence and X-Ray Powder Diffraction techniques extensively for characterising substances of all kinds – organic as well as inorganic. I have been using both techniques within Ilford/HARMAN since the early-mid 1980’s, though I’d used both in my university research as well – the XRPD I did at university mostly used Guinier cameras rather than a diffractometer! In my present job, the X-ray techniques are used in conjunction with a wide range of other techniques involving wet chemistry as well as instrumental analysis.

Miss Katy Alexander – KatyAlexander@eurofins.com (Treasurer)

 I am currently a group leader with Eurofins PSS, supporting the pharmaceutical development of both early and late stage candidates in a materials sciences team.

Prior to joining Eurofins, I supported solid state characterisation and solid form screening activities at Pfizer and at Solid Form Solutions, a contract research organisation. My current role has enabled me to continue in this technical field with additional focus on characterising and understanding API form in drug product.

The Committee members:

Dr Anthony Bell – Anthony.Bell@shu.ac.uk

First degree in Chemistry at University of Sheffield 1981-84, in my final year I did a single-crystal research project which got me into crystallography. This helped me get my first job with AEA Technology near Preston (1985-90) when I did X-ray powder diffraction on nuclear and non-nuclear materials. I then left for academia; I worked at the Daresbury Synchrotron Radiation Source 1990-95, where I got a M.Sc. in chemistry from Keele. I then went up to Cambridge University to be a mature PhD student in chemistry (1995-99). I then did postdocs in Montpellier (France), Oxford and Manchester before returning to Daresbury (2005-8) to be a powder diffraction beamline scientist. After the closure of the Daresbury SRS in 2008 I went to Hamburg in Germany (2009-12) to be a powder diffraction beamline scientist on the DORIS synchrotron. I returned to the UK in 2013 and worked as an XRD/SEM experimental officer at Newcastle University 2014-15. In 2015 I returned to Sheffield where I run an XRD/XRF laboratory at Sheffield Hallam University. My research interests are powder diffraction, synchrotron radiation and crystal structures of minerals from powder data.

Dr Luca Russo – luca.x.russo@gsk.com  

Currently working as crystallographer for GlaxoSmithKline (GSK) in the Physical Properties department, part of product development, with main remit in the structural characterisation and property modelling of crystalline drug substances. After a PhD in supramolecular chemistry and Single-Crystal XRD methods at Newcastle University with Prof. Bill Clegg, I have been working as PDRA in crystallography for some years in the research groups of Prof. Kari Rissanen (Jyväskylä University, FI) and Prof. Bill Clegg, before moving on to the more technological side of things, working as XRD application scientist for Rigaku Europe, previous to my current role. Main scientific interests: Single-Crystal XRD, XRPD structure solution & Rietveld refinement, physical properties of crystalline materials, structural informatics, Pair Distribution Function.

Miss Judith Shackleton – judith.shackleton@rolls-royce.com

I have worked in XRD for over 40 years and am currently a Principal Technologist for Rolls-Royce plc, in Materials Engineering, Derby.

My interests are all things inorganic, aerospace materials, nickel and titanium alloys, contaminants, coatings, etc.

Applications, mainly Residual Stress, Phase Identification and Texture Analysis.

Dr Irina Gordovskaya – irina.gordovskaya@nsg.com

I graduated from University of Manchester with a PhD supervised by Prof. George Thompson and Prof. Peter Skeldon (corrosion protection of aluminium alloys using rare earth species).

Currently working as advanced technologist for NSG Group in the Surface analysis and materials properties department, providing technical support for manufacturing lines and teams within the R&D.

Dr Natalie Johnson – njohnson@ccdc.cam.ac.uk

I am currently a post-doctoral researcher at the Cambridge Crystallographic Data Centre, working in data integrity.

My main area of research is in the completeness of data within the Cambridge Structural Database – a database of 1 million small-molecule organic and metal organic crystal structures. I also explore ways to identify and investigate any fraudulent or plagiarised data within the database.

Previously, I was a PhD student at Newcastle University, investigating the reproducibility of charge density data refinements.